ARCTIC BIOSCIENCE ASARCTIC BIOSCIENCE ASARCTIC BIOSCIENCE AS

ARCTIC BIOSCIENCE AS

No trades
See on Supercharts

ABS fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. It develops novel, oral pharmaceutical treatment for mild-to-moderate psoriasis. It also supplies nutraceutical ingredients and finished products for dietary supplements. The company was founded by Hogne Hallaraker, Harald Nordal, and Jan Brevig Remmerelt in 2011 and is headquartered in Orsta, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ABS does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company